samedi 17 septembre 2011

Press review (September 17, 2011) – Revue de presse (17 septembre 2011)

Breast and cervical cancer rates rising globally
Review says the diseases could overtake maternal mortality as a cause of death in younger women in the developing world.
By Sarah Boseley. In The Guardian

New Global Killers: Heart, Lung Disease and Cancer
Next week, the U.N. General Assembly will hold its first summit on chronic diseases--cancer, diabetes and heart and lung disease, which have common risk factors, such as smoking and sedentary lifestyles, and many are preventable.
By Marilynn Marchione. In ABC News

NSAID Painkillers Linked to Risk of Kidney Cancer
The long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as Advil, Motrin and Aleve may slightly increase the risk for developing kidney cancer, Harvard researchers report.
By Steven Reinberg. In U.S. News & World Report

UPenn Doctors Reconstruct T-Cells Used to Kill Leukemia
University of Pennsylvania doctors have used gene therapy to train a patient's own immune system to kill leukemia cells.
By Greg Howard. In Slate Magazine

Women with BRCA mutations get cancer diagnosis earlier
Women with the genetic BRCA mutations, known to be at higher risk of developing breast and ovarian cancers, are being diagnosed with those cancers earlier than previous generations, researchers now report.
By Kathleen Doheny. In USA Today

Protein discovered at LSUHSC may suppress breast cancer growth
Research led by Dr. Suresh Alahari, the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans and its Stanley S. Scott Cancer Center, has found that nischarin, a protein discovered by his laboratory can inhibit the growth of breast cancer cells. The research will be published September 14, 2011 online in the Journal of the National Cancer Institute.
In EurekAlert (press release)

Oncology Drug Applications Migrate in FDA Reorganization‎
Many New Drug Applications, Biologic License Applications, and Investigational New Drug Applications for cancer drugs are being reassigned to new review divisions as part of a reorganization of the Food and Drug Administration’s Office of Oncology Products.
By Emily Hayes. In The Oncology Report

British flowers are the source of a new cancer drug
The search for more effective cancer treatments may soon harness the healing power of the Autumn crocus.
By Leila Battison. In BBC News

New technique shows how 'cancer-fighting' white blood cells kill diseased tissue‎‎
Scientists from Imperial College London and the University of Oxford have used a super-resolution microscope to capture how certain white blood cells - called natural killer (NK) cells - kill diseased tissue in greater detail than ever before.
In Cancer Research UK

Les cancers du sein en forte hausse au cours des 30 dernières années‎
Le nombre des cancers du sein a connu une forte hausse en 30 ans, avec une estimation de 640.000 nouveaux cas en 1980 et de 1,6 million en 2010 (+260%), dont la moitié dans des pays en voie de développement, selon une étude publiée en ligne par la revue britannique The Lancet.

Cancers du sein : découverte d'un marqueur de risque de métastases pulmonaires
Des chercheurs français ont identifié un marqueur du risque de développer des métastases pulmonaires chez les femmes atteintes de cancers du sein, selon des travaux publiés mardi. En agissant sur ce marqueur, dénommé "Kindlin-1", les chercheurs espèrent pouvoir bloquer la prolifération des cellules tumorales et ainsi contenir le pouvoir agressif des tumeurs à fort risque de dissémination pulmonaire.

Aucun commentaire:

Enregistrer un commentaire